NASDAQ:KROS

Keros Therapeutics Stock Forecast

etoro logo Buy KROS
*Your capital is at risk
$11.15
+0.500 (+4.69%)
At Close: Aug 07, 2026

Should you buy KROS stock?

Last updated:

Based on market data through , StockInvest.us rates Keros Therapeutics Inc. (KROS) as a Buy Candidate with a technical score of 4.01 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.

  • Buy signal since
  • Price since signal Flat 0.00%
  • 3-month trend forecast Down 5.63%
  • Buy Candidate 4.01
AI Analysis AI Analysis of KROS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KROS to Watchlist?
Some Reasons Why To Add KROS:
  • High gross margin of 94.7%
  • Low bankruptcy risk (Altman Z-Score: 5.99)
  • Highly efficient cash conversion (101% FCF/OCF ratio)
PDF

Keros Therapeutics Inc. stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Market data through Aug 07, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Aug 07, 2026

The Keros Therapeutics Inc. stock price gained 4.69% on the last trading day (Friday, 7th Aug 2026), rising from $10.65 to $11.15. During the last trading day the stock fluctuated 6.43% from a day low at $10.58 to a day high of $11.26. The price has risen in 6 of the last 10 days and is up by 10.83% over the past 2 weeks. Volume fell on the last day by -68 thousand shares and in total, 319 thousand shares were bought and sold for approximately $3.55 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.63% during the next 3 months and, with a 90% probability hold a price between $8.76 and $11.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

KROS Signals & Forecast

Mostly positive signals in the chart today. The Keros Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $10.35 and $10.72. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 11.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Wednesday, June 10, 2026 and based on theory for this formation the price should go up by 9.83% to $12.25 within 15 trading days (Thursday, July 02, 2026) since signal was issued.

Support, Risk & Stop-loss for Keros Therapeutics Inc. stock

Keros Therapeutics Inc. finds support from accumulated volume at $10.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.680 between high and low, or 6.43%. For the last week, the stock has had daily average volatility of 5.78%.

Our recommended stop-loss: $10.78 (-3.32%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (KROS) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Keros Therapeutics Inc. to open at $11.00, and during the day (based on 14 day Average True Range), to move between $10.89 and $11.41, which gives a possible trading interval of +/-$0.513 (+/-4.71%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $11.23 (0.72%) than the support at $10.99 (1.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Keros Therapeutics Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 4.008 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 10, 2026 - $11.00 ( 1.38%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KROS Performance

Trading levels for KROS

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 11.68 4.72%
R2 11.42 2.39%
R1 11.26 0.95%
Price 11.15
S1 10.74 -3.71%
S2 10.58 -5.15%
S3 10.32 -7.48%

Accumulated Volume Support & Resistance Levels

Level Price
R3 11.65 4.48%
R2 11.26 0.99%
R1 11.23 0.717%
Price 11.15
S1 10.99 -1.43%
S2 10.98 -1.52%
S3 10.65 -4.48%

FAQ

What is the symbol for Keros Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Keros Therapeutics Inc. is KROS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Keros Therapeutics Inc. Stock?
Based on market data through Aug 07, 2026, StockInvest.us rates Keros Therapeutics Inc. (KROS) as a Buy Candidate with a technical score of 4.01 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation. Since the Buy signal began on Aug 07, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 5.63%.

How to buy Keros Therapeutics Inc. Stock?
Keros Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.

What's the current price of Keros Therapeutics Inc. Stock?
As of the end of day on the Aug 07, 2026, the price of an Keros Therapeutics Inc. (KROS) share was $11.15.

What is the 52-week high and low for Keros Therapeutics Inc. Stock?
The 52-week high for Keros Therapeutics Inc. Stock is $22.55 and the 52-week low is $9.69.

What is the market capitalization of Keros Therapeutics Inc. Stock?
As of the Aug 07, 2026, the market capitalization of Keros Therapeutics Inc. is 356.778M.

When is the next earnings date for Keros Therapeutics Inc.?
The upcoming earnings date for Keros Therapeutics Inc. is Nov 04, 2026.
Click to get the best stock tips daily for free!
ABOUT KEROS THERAPEUTICS INC.
Keros Therapeutics
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in pat...
GOLDEN STAR
Ticker Change Signal Date
MHO
$150.54
0.96% Aug 05
JEF
$55.71
1.63% Aug 04
FCX
$62.63
11.16% Jul 31
BIIB
$202.19
2.84% Jul 24
S
SW
$43.71
10.46% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE